COMPARATIVE SERUM PREDNISONE AND PREDNISOLONE CONCENTRATIONS FOLLOWING ADMINISTRATION TO PATIENTS WITH CHRONIC ACTIVE LIVER-DISEASE

被引:14
作者
URIBE, M
SUMMERSKILL, WHJ
GO, VLW
机构
[1] INST NACL NUTR,LIVER UNIT,MEXICO CITY 22,DF,MEXICO
[2] MAYO CLIN & MAYO FDN,GASTROENTEROL UNIT,ROCHESTER,MN 55901
关键词
D O I
10.2165/00003088-198207050-00005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:452 / 459
页数:8
相关论文
共 17 条
[11]  
SOLOWAY RD, 1972, GASTROENTEROLOGY, V63, P820
[12]  
URIBE M, 1976, GASTROENTEROLOGY, V71, P362
[13]   CORTICOSTEROID PHARMACOKINETICS IN LIVER-DISEASE [J].
URIBE, M ;
GO, VLW .
CLINICAL PHARMACOKINETICS, 1979, 4 (03) :233-240
[14]   ORAL PREDNISONE FOR CHRONIC ACTIVE LIVER-DISEASE - DOSE RESPONSES AND BIOAVAILABILITY STUDIES [J].
URIBE, M ;
SCHALM, SW ;
SUMMERSKILL, WHJ ;
GO, VLW .
GUT, 1978, 19 (12) :1131-1135
[15]  
URIBE M, 1976, GASTROENTEROLOGY, V71, P932
[16]  
URIBE M, 1981, GASTROENTEROLOGY, V80, P261
[17]   THE METABOLISM OF 4-C-14 PREDNISOLONE [J].
VERMEULEN, A .
JOURNAL OF ENDOCRINOLOGY, 1959, 18 (03) :278-291